BR100 Increased By (0.2%)
BR30 Increased By (0.41%)
KSE100 Increased By (0.07%)
KSE30 Increased By (0.23%)
AGHA 7.75 Decreased By ▼ -0.17 (-2.15%)
BECO 5.19 Decreased By ▼ -0.01 (-0.19%)
BML 58.66 Decreased By ▼ -0.59 (-1%)
BOP 33.69 Increased By ▲ 0.01 (0.03%)
CNERGY 10.61 Increased By ▲ 0.80 (8.15%)
CSIL 5.30 Decreased By ▼ -0.12 (-2.21%)
FCCL 53.74 Increased By ▲ 0.22 (0.41%)
FFL 16.46 Decreased By ▼ -0.22 (-1.32%)
FNEL 1.22 Increased By ▲ 0.01 (0.83%)
KEL 7.28 Decreased By ▼ -0.07 (-0.95%)
KOSM 5.64 Increased By ▲ 0.03 (0.53%)
LOTCHEM 29.65 Increased By ▲ 0.54 (1.86%)
MLCF 96.36 Increased By ▲ 0.86 (0.9%)
NBP 203.53 Decreased By ▼ -0.82 (-0.4%)
NCPL 56.85 Decreased By ▼ -1.39 (-2.39%)
NPL 67.31 Decreased By ▼ -0.48 (-0.71%)
OGDC 318.22 Increased By ▲ 0.28 (0.09%)
PACE 10.63 Decreased By ▼ -0.08 (-0.75%)
PAEL 41.77 Decreased By ▼ -0.06 (-0.14%)
PIBTL 16.81 Increased By ▲ 0.31 (1.88%)
PPL 220.17 Increased By ▲ 0.43 (0.2%)
PRL 49.05 Increased By ▲ 4.46 (10%)
PTC 70.01 Decreased By ▼ -0.76 (-1.07%)
SSGC 29.14 Increased By ▲ 0.21 (0.73%)
TBL 9.77 Decreased By ▼ -0.07 (-0.71%)
TELE 8.82 Increased By ▲ 0.06 (0.68%)
TPL 17.17 Increased By ▲ 0.72 (4.38%)
TPLP 12.51 Increased By ▲ 0.41 (3.39%)
TREET 22.59 Decreased By ▼ -0.21 (-0.92%)
TRG 60.22 Increased By ▲ 0.19 (0.32%)
Opinion Print edition: 2023-04-30

Hike in drug prices

Published Updated

How ironic it is that the pharmaceutical sector of Pakistan considers a 20 percent hike in the prices of essential drugs too little or too small. Rejecting the government move of raising drug prices through Economic Coordination Committee (ECC) of the Cabinet the other day, the drug manufacturers have demanded the government give them a 40 percent hike in accordance with the inflation rate.

It is however important to note that a number of drug-making companies had stopped producing certain essential and non-essential drugs to the sheer chagrin or discomfort of people many months ago.

This has allowed the unscrupulous people to hoard such drugs and sale them on exorbitant rates in black market. These companies had cited import restrictions as a reason that had caused a huge impediment to their ability to import raw materials and active ingredients to produce the much-needed drugs that had completely disappeared from the shelves of medical stores.

It is quite true that import curbs have adversely affected manufacturing sector in a big way. But the pharma sector’s questionable approach to import curbs has added to the human misery, so to speak.

Be that as it may, the 20 percent hike in drug prices is already quite significant or big. Rejecting this raise and demanding a much higher increase in drug prices is a step aimed at exerting udue pressure on the government. In my view, the relevant authorities must not succumb to such tactics in the larger interest of ailing people in particular.

Hammad Tahir (Lahore)

Copyright Business Recorder, 2023

Comments

Comments are closed for this article.